Transphorm Appoints Katharina McFarland to Board of Directors
Transphorm (OTCQB: TGAN) announced the appointment of Katharina McFarland to its Board of Directors, effective February 23, 2021. McFarland brings over 30 years of government expertise in acquisition and program management, having served in key roles within the Department of Defense. Her experience is expected to enhance Transphorm’s relationships with government agencies, particularly in the GaN sector. CEO Mario Rivas emphasized her unique insights and the company's commitment to board diversification amidst its strategic growth plan in GaN power conversion.
- Appointment of Katharina McFarland enhances board expertise and diversification.
- McFarland's government acquisition experience may strengthen relationships with DoD and government agencies.
- None.
Transphorm, Inc. (“Transphorm” or the “Company”) (OTCQB: TGAN)—a pioneer in and global supplier of high reliability, high performance gallium nitride (GaN) power conversion products—today announced the appointment of Katharina McFarland to the Company’s Board of Directors, effective February 23, 2021.
With over 30 years of government service, McFarland is widely recognized as a leading subject-matter expert on government acquisition, program management and procurement. She is currently the president of Blue Oryx Inc., a consulting services firm. Previously, McFarland served as the Assistant Secretary of Defense for Acquisition and Acting Assistant Secretary of the Army for Acquisitions, Logistics & Technology as the Army’s Service Acquisition Executive and Chief Science Advisor. Prior to her political appointments, McFarland held roles as the President of the Defense Acquisition University, and the Director for Acquisition at the Missile Defense Agency. McFarland currently serves as a director on the board of Science Applications International Corporation (NYSE: SAIC), which had acquired Engility Holdings, Inc., where she previously served as a director. McFarland holds a Bachelor of Science degree in engineering from Queen’s University, a master’s degree in program management from the Program Management Institute, and an honorary doctoral degree in engineering from Cranfield University.
“Katharina is a highly respected expert in her field, and we are pleased to welcome her as a new independent director,” stated Mario Rivas, Transphorm’s Chief Executive Officer. “Her unique and extensive experience in government service and procurement brings a new and informed perspective, which is highly relevant to our current and prospective GaN business with the DoD and other government agencies, while also serving to expand the depth and expertise of our Board. This appointment also demonstrates our commitment to board diversification in order to further strengthen the breadth, talent and background of our directors. I look forward to Katharina’s valuable contributions to Transphorm as we continue to execute on our strategic growth plan.”
About Transphorm, Inc.
Transphorm, Inc., a global leader in the GaN revolution, designs and manufactures high performance and high reliability GaN semiconductors for high voltage power conversion applications. Having one of the largest Power GaN IP portfolios of more than 1,000 owned or licensed patents, Transphorm produces the industry’s first JEDEC and AEC-Q101 qualified high voltage GaN semiconductor devices. The Company’s vertically integrated device business model allows for innovation at every development stage: design, fabrication, device, and application support. Transphorm’s innovations are moving power electronics beyond the limitations of silicon to achieve over
View source version on businesswire.com: https://www.businesswire.com/news/home/20210224005499/en/
FAQ
What is the significance of Katharina McFarland's appointment to Transphorm's board?
How does Katharina McFarland's background benefit Transphorm?
When was Katharina McFarland appointed to the Board of Directors of Transphorm?
What company does Transphorm operate in?
